



Dr. Reddy's Laboratories |
You are here: Home > Pharmacy News | Health Articles/Tips > Dr. Reddy's Laboratories
Latest News - Dr. Reddy's Laboratories
Dr Reddy's buys GSK's oral penicillin facility in USUS-based pharma major GlaxoSmithKline and Indian drug giant Dr Reddy’s Laboratories, have signed an agreement relating to GSK’s United States oral penicillin facility and product portfolio. Under the agreement, GSK will transfer ownership of its penicillin manufacturi...READ MORE>>November 30, 2010 |
Dr Reddy's wants FDA to change rulesThe $1.6-billion Dr Reddy's Laboratories, shares of which are listed both in India and US stock markets, has knocked the doors of US Food and Drug Administration...READ MORE>>September 13, 2010 |
Dr Reddy's gets US nod for Prograf generic and expects 20 per cent in FY11 newsAfter Sandoz, Dr Reddy's Laboratories has become the second company to gain the approval from US regulator to launch tacrolimus capsules, a generic equivalent of Japan's second-largest drug maker Astellas Pharma's Prograf, also sold under the brand name Advagraf by Astell...READ MORE>>May 24, 2010 |
News Archives - 2010